Molecular characterisation of a recurrent, semi-cryptic RUNX1 translocation t(7;21) in myelodysplastic syndrome and acute myeloid leukaemia: Research paper

British Journal of Haematology

Volumn 148, Issue 6, 2010, Pages 938-943

  Foster, Nicola ^a   Paulsson, Kajsa ^b   Sales, Mark ^a   Cunningham, Joan ^a   Groves, Michael ^a   O'Connor, Nigel ^c   Begum, Suriya ^d   Stubbs, Tracy ^d   McMullan, Dominic J ^d   Griffiths, Michael ^d   Pratt, Norman ^a   Tauro, Sudhir ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c ROYAL SHREWSBURY HOSPITAL   (United Kingdom)

^d BIRMINGHAM CHILDREN S HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Acute myeloid leukaemia; Myelodysplastic syndrome; RUNX1 USP42

Indexed keywords

HYBRID PROTEIN; TRANSCRIPTION FACTOR RUNX1; RUNX1 PROTEIN, HUMAN; TUMOR PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; CELL STRUCTURE; CHROMOSOME ANALYSIS; CONTROLLED STUDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE SEQUENCE; GENE TRANSLOCATION; GENETIC VARIABILITY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; RECURRENT DISEASE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SPLICING; SINGLE NUCLEOTIDE POLYMORPHISM; CHILD; CHROMOSOME 21; CHROMOSOME 7; GENETICS; PROCEDURES;

AGED; CHILD; CHROMOSOMES, HUMAN, PAIR 21; CHROMOSOMES, HUMAN, PAIR 7; CORE BINDING FACTOR ALPHA 2 SUBUNIT; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LEUKEMIA, MYELOID, ACUTE; MALE; MYELODYSPLASTIC SYNDROMES; NEOPLASM PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSLOCATION, GENETIC;

EID: 77649196731     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2009.08039.x     Document Type: Article

References (19)

1. Bayani, J. Squire, J.A. (2001) Advances in the detection of chromosomal aberrations using spectral karyotyping. Clinical Genetics, 59, 65 73.
2. Gebhart, E. (2005) Genomic imbalances in human leukemia and lymphoma detected by comparative genomic hybridization (Review). International Journal of Oncology, 27, 593 606.
3. Grimwade, D., Howe, K., Langabeer, S., Davies, L., Oliver, F., Walker, H., Swirsky, D., Wheatley, K., Goldstone, A., Burnett, A. Solomon, E. (1996) Establishing the presence of the t(15;17) in suspected acute promyelocytic leukaemia: cytogenetic, molecular and PML immunofluorescence assessment of patients entered into the M.R.C. ATRA trial. M.R.C. Adult Leukaemia Working Party. British Journal of Haematology, 94, 557 573.
4. Iafrate, A.J., Feuk, L., Rivera, M.N., Listewnik, M.L., Donahoe, P.K., Qi, Y., Scherer, S.W. Lee, C. (2004) Detection of large-scale variation in the human genome. Nature Genetics, 36, 949 951.
5. Jacobsson, B., Bernell, P., Arvidsson, I. Hast, R. (1996) Classical morphology, esterase cytochemistry and interphase cytogenetics of peripheral blood and bone marrow smears. Journal of Histochemistry and Cytochemistry, 44, 1303 1309.
6. Kolomietz, E., Marrano, P., Yee, K., Thai, B., Braude, I., Kolomietz, A., Chun, K., Minkin, S., Kamel-Reid, S., Minden, M. Squire, J.A. (2003) Quantitative PCR identifies a minimal deleted region of 120 kb extending from the Philadelphia chromosome ABL translocation breakpoint in chronic myeloid leukemia with poor outcome. Leukemia, 17, 1313 1323.
7. Lugthart, S., van Drunen, E., van Norden, Y., van Hoven, A., Erpelinck, C.A., Valk, P.J., Beverloo, H.B., Löwenberg, B. Delwel, R. (2008) High EVI1 levels predict adverse outcome in acute myeloid leukemia: prevalence of EVI1 overexpression and chromosome 3q26 abnormalities underestimated. Blood, 111, 4329 4337.
8. Miyamoto, T., Weissman, I.L. Akashi, K. (2000) AML1/ETO-expressing nonleukemic stem cells in acute myelogenous leukemia with 8;21 chromosomal translocation. Proceedings of the National Academy of Sciences of the United States of America, 97, 7521 7526.
9. Miyoshi, H., Ohira, M., Shimizu, K., Mitani, K., Hirai, H., Imai, T., Yokoyama, K., Soeda, E. Ohki, M. (1995) Alternative splicing and genomic structure of the AML1 gene involved in acute myeloid leukemia. Nucleic Acids Research, 23, 2762 2769.
10. Nucifora, G. Rowley, J.D. (1995) AML1 and the 8;21 and 3;21 translocation in acute and chronic myeloid leukemia. Blood, 86, 1 14.
11. Paschka, P., Marcucci, G., Ruppert, A.S., Mrózek, K., Chen, H., Kittles, R.A., Vukosavljevic, T., Perrotti, D., Vardiman, J.W., Carroll, A.J., Kolitz, J.E., Larson, R.A. Bloomfield, C.D. (2006) Adverse prognostic significance of KIT mutations in adult acute myeloid leukemia with inv(16) and t(8;21): a Cancer and Leukemia Group B Study. Journal of Clinical Oncology, 24, 3904 3911. (Pubitemid 46630738)
12. Paulsson, K., Békássy, A.N., Olofsson, T., Mitelman, F., Johansson, B. Panagopoulos, I. (2006) A novel and cytogenetically cryptic t(7;21)(p22;q22) in acute myeloid leukemia results in fusion of RUNX1 with the ubiquitin-specific protease gene USP42. Leukemia, 20, 224 229.
13. Peterson, L.F., Boyapati, A., Ahn, E.Y., Biggs, J.R., Okumura, A.J., Lo, M.C., Yan, M. Zhang, D.E. (2007) Acute myeloid leukemia with the 8q22;21q22 translocation: secondary mutational events and alternative t(8;21) transcripts. Blood, 110, 799 805.
14. Shaffer, L.G. Tommerup, N. (eds 2005) An International System for Human Cytogenetic Nomenclature (ISCN). S. Karger, Basel.
15. Shurtleff, S.A., Buijs, A., Behm, F.G., Rubnitz, J.E., Raimondi, S.C., Hancock, M.L., Chan, G.C., Pui, C.H., Grosveld, G. Downing, J.R. (1995) TEL/AML1 fusion resulting from a cryptic t(12;21) is the most common genetic lesion in pediatric ALL and defines a subgroup of patients with an excellent prognosis. Leukemia, 9, 1985 1989.
16. Tchinda, J., Volpert, S., McNeil, N., Neumann, T., Kennerknecht, I., Ried, T., Büchner, T., Serve, H., Berdel, W.E., Horst, J. Hilgenfeld, E. (2003) Multicolor karyotyping in acute myeloid leukemia. Leukaemia & Lymphoma, 44, 1843 1853.
17. Wiemels, J.L. Greaves, M. (1999) Structure and possible mechanisms of TEL-AML1 gene fusions in childhood acute lymphoblastic leukemia. Cancer Research, 59, 4075 4082.
18. Yan, M., Kanbe, E., Peterson, L.F., Boyapati, A., Miao, Y., Wang, Y., Chen, I.M., Chen, Z., Rowley, J.D., Willman, C.L. Zhang, D.E. (2006) A previously unidentified alternatively spliced isoform of t(8;21) transcript promotes leukemogenesis. Nature Medicine, 12, 945 949.
19. Yuan, Y., Zhou, L., Miyamoto, T., Iwasaki, H., Harakawa, N., Hetherington, C.J., Burel, S.A., Lagasse, E., Weissman, I.L., Akashi, K. Zhang, D.E. (2001) AML1-ETO expression is directly involved in the development of acute myeloid leukemia in the presence of additional mutations. Proceedings of the National Academy of Sciences of the United States of America, 98, 10398 10403. (Pubitemid 32803031)